CHO-H01

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameCHO-H01
Drug Alias NameCHO-H01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-CD20
TargetsB-lymphocyte antigen CD20
Therapy Area/IndicationsLymphoma, Non-HodgkinNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAcademia Sinica
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLymphoma, Non-HodgkinNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A